The project is charting a course toward more rigorous, coherent methods for ESG integration, with four key goals that are relevant to asset owners and managers, as well as regulators.
At Ceres, Chris Fox leads collaborative, goal-based work with investors to limit global warming.
Markus Perschl seeks rapid iteration in an industry known for steadiness.
MIT takes top business and economics spot in world ranking
The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced a new initiative, Project ALPHA (Analytics for Life-sciences Professionals and Healthcare Advocates).
COVID-19 has exacerbated inequality worldwide. Central banking experts from the U.S., Finland, and Malaysia discuss if and how central banks can help.
A recent study by MIT Sloan Visiting Associate Prof. of Finance Matthew Rhodes-Kropf systematically documents how technological shocks have substantially lowered the cost of starting new businesses.
The SEC is proposing a new rule that would require public companies to disclose their emissions data and create more transparency. Industry experts unpack its implications.
Voluntary climate commitments by financial institutions aren’t having a positive impact, research finds. But banks do have time to reverse course and make progress.
MIT Sloan and CSAIL researchers apply artificial intelligence techniques to one of the largest datasets of clinical trial outcomes to handicap the drug and device approval process
